The effects of PPAR-γ agonist pioglitazone on renal ischemia/reperfusion injury in rats

Journal of Surgical Research

Volumn 182, Issue 1, 2013, Pages 176-184

  Reel, Buket ^a   Guzeloglu, Mehmet ^b   Bagriyanik, Alper ^c   Atmaca, Soner ^c   Aykut, Koray ^b   Albayrak, Gokhan ^b   Hazan, Eyup ^b  

^a EGE UNIVERSITY   (Turkey)

^b IZMIR UNIVERSITY   (Turkey)

^c DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Inflammation; MMP; Oxidative stress; PPAR agonist; Renal ischemia reperfusion

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; GELATINASE A; GELATINASE B; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; PLACEBO; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENTERITIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KIDNEY ISCHEMIA; KIDNEY NECROSIS; KIDNEY TUBULE NECROSIS; MALE; NEPHRECTOMY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SCORING SYSTEM;

ANIMALS; ANTIOXIDANTS; KIDNEY; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MODELS, ANIMAL; NADPH OXIDASE; OXIDATIVE STRESS; PHOSPHOPROTEINS; PPAR GAMMA; RATS; RATS, WISTAR; REPERFUSION INJURY; SUPEROXIDE DISMUTASE; THIAZOLIDINEDIONES; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 84876668654     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.08.020     Document Type: Article

References (52)

1. P.R. McCombs, and B. Roberts Acute renal failure following resection of abdominal aortic aneurysm Surg Gynecol Obstet 148 1979 175
2. S.P. Pinney, R. Balakrishnan, and S. Dikman Histopathology of renal failure after heart transplantation: a diverse spectrum J Heart Lung Transplant 31 2012 233
3. K.A. Nath, and S.M. Norby Reactive oxygen species and acute renal failure Am J Med 109 2000 665
4. P.K. Chatterjee Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review Naunyn Schmiedebergs Arch Pharmacol 376 2007 1
5. H. Rabb, C.C. Mendiola, and J. Dietz Role of CD11a and CD11b in ischemic acute renal failure in rats Am J Physiol 267 1994 1052
6. A.M. Sheridan, and J.V. Bonventre Cell biology and molecular mechanisms of injury in ischemic acute renal failure Curr Opin Nephrol Hypertens 9 2000 427
7. T.A. Sutton, H.E. Mang, and S.B. Campos Injury of the renal microvascular endothelium alters barrier function following ischemia Am J Physiol Renal Physiol 285 2003 191
8. H. Nagase, and J.F. Woessner Jr. Matrix metalloproteinases J Biol Chem 274 1999 21491
9. A.C. Newby Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates Cardiovasc Res 69 2006 614
10. J.M. Catania, G. Chen, and A.R. Parrish Role of matrix metalloproteinases in renal pathophysiologies Am J Physiol Renal Physiol 292 2007 905
11. E. Dejonckheere, R.E. Vandenbroucke, and C. Libert Matrix metalloproteinases as drug targets in ischemia/reperfusion injury Drug Discov Today 16 2011 762
12. M. Ricote, A.C. Li, and T.M. Willson The peroxisome proliferator- activated receptor-gamma is a negative regulator of macrophage activation Nature 391 1998 79
13. M. van Bilsen, and F.A. van Nieuwenhoven PPARs as therapeutic targets in cardiovascular disease Expert Opin Ther Targets 14 2010 1029
14. E. Robinson, and D.J. Grieve Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease Pharmacol Ther 122 2009 246
15. A. von Knethen, and B. Brüne PPARgamma-an important regulator of monocyte/macrophage function Arch Immunol Ther Exp (Warsz) 51 2003 219
16. M.D. Li, and X. Yang A retrospective on nuclear receptor regulation of inflammation: lessons from GR and PPARs PPAR Res 2011 2011 742785
17. X. Wang, Z. Wang, and J.Z. Liu Double antioxidant activities of rosiglitazone against high glucose-induced oxidative stress in hepatocyte Toxicol In Vitro 25 2011 839
18. S. Giannini, M. Serio, and A. Galli Pleiotropic effects of thiazolidinediones: taking a look beyond antidiabetic activity J Endocrinol Invest 27 2004 982
19. A. Sivarajah, P.K. Chatterjee, and N.S. Patel Agonists of peroxisome-proliferator activated receptor-gamma reduce renal ischemia/reperfusion injury Am J Nephrol 23 2003 267
20. M. Abdelrahman, A. Sivarajah, and C. Thiemermann Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock Cardiovasc Res 65 2005 772
21. H. Ito, A. Nakano, and M. Kinoshita Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia/reperfusion injury in a rat model Lab Invest 83 2003 1715
22. T. Akahori, M. Sho, and K. Hamada Importance of peroxisome proliferator-activated receptor-gamma in hepatic ischemia/reperfusion injury in mice J Hepatol 47 2007 784
23. Z. Cao, P. Ye, and C. Long Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats Pharmacology 79 2007 184
24. M.H. Somi, B. Hajipour, and N.A. Asl Pioglitazone attenuates ischemia/reperfusion-induced liver injury in rats Transplant Proc 41 2009 4105
25. C. Rice-Evans, and N.J. Miller Total antioxidant status in plasma and body fluids Methods Enzymol 234 1994 279
26. O. Erel A novel automated method to measure total antioxidant response against potent free radical reactions Clin Biochem 37 2004 112
27. M. Guzeloglu, F. Yalcinkaya, and S. Atmaca The beneficial effects of tadalafil on renal ischemia-reperfusion injury in rats Urol Int 86 2011 197
28. C. Ellenberger, A. Schweizer, and J. Diaper Incidence, risk factors, and prognosis of changes in serum creatinine early after aortic abdominal surgery Intensive Care Med 32 2006 1808
29. C.F. Cheng, W.S. Lian, and S.H. Chen Protective effects of adiponectin against renal ischemia-reperfusion injury via prostacyclin-PPARα-heme oxygenase-1 signaling pathway J Cell Physiol 227 2012 239
30. M. Collino, E. Benetti, and G. Miglio Peroxisome proliferator-activated receptor β/δ agonism protects the kidney against ischemia/reperfusion injury in diabetic rats Free Radic Biol Med 50 2011 345
31. M. Matsuyama, R. Yoshimura, and Y. Kawahito Relationship between peroxisome proliferator-activated receptor-γ and renal ischemia-reperfusion injury Mol Med Report 1 2008 499
32. G. Miglio, A.C. Rosa, and L. Rattazzi The subtypes of peroxisome proliferator-activated receptors expressed by human podocytes and their role in decreasing podocyte injury Br J Pharmacol 162 2011 111
33. N.S. Patel, R. di Paola, and E. Mazzon Peroxisome proliferator-activated receptor-alpha contributes to the resolution of inflammation after renal ischemia/reperfusion injury J Pharmacol Exp Ther 328 2009 635
34. D. Bishop-Bailey, and J. Bystrom Emerging roles of peroxisome proliferator-activated receptor-beta/delta in inflammation Pharmacol Ther 124 2009 141
35. C. Jiang, A.T. Ting, and B. Seed PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines Nature 391 1998 82
36. G. Chinetti, S. Griglio, and M. Antonucci Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages J Biol Chem 273 1998 25573
37. M. Ricote, J.T. Huang, and J.S. Welch The peroxisome proliferator- activated receptor (PPARgamma) as a regulator of monocyte/macrophage function J Leukoc Biol 66 1999 733
38. Y. Naito, T. Takagi, and K. Uchiyama Suppression of intestinal ischemia-reperfusion injury by a specific peroxisome proliferator-activated receptor-gamma ligand, pioglitazone, in rats Redox Rep 7 2002 294
39. H. Ichikawa, Y. Naito, and T. Takagi A specific peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligand, pioglitazone, ameliorates gastric mucosal damage induced by ischemia and reperfusion in rats Redox Rep 7 2002 343
40. K. Ito, J. Shimada, and D. Kato Protective effects of preischemic treatment with pioglitazone, a peroxisome proliferator-activated receptor-ligand, on lung ischemia-reperfusion injury in rats Eur J Cardiothorac Surg 25 2004 530
41. N.S. Wayman, Y. Hattori, and M.C. McDonald Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size FASEB J 16 2002 1027
42. B. Betz, R. Schneider, and T. Kress Rosiglitazone affects nitric oxide synthases and improves renal outcome in a rat model of severe ischemia/reperfusion injury PPAR Res 2012 2012 219319
43. H. Hu, C. Zou, and X. Xi Protective effects of pioglitazone on renal ischemia-reperfusion injury in mice J Surg Res 2012 in press
44. D.P. Basile, K. Fredrich, and D. Weihrauch Angiostatin and matrix metalloprotease expression following ischemic acute renal failure Am J Physiol Renal Physiol 286 2004 893
45. K.B. Novak, H.D. Le, and E.R. Christison-Lagay Effects of metalloproteinase inhibition in a murine model of renal ischemia-reperfusion injury Pediatr Res 67 2010 257
46. S. Kunugi, A. Shimizu, and N. Kuwahara Inhibition of matrix metalloproteinases reduces ischemia-reperfusion acute kidney injury Lab Invest 91 2011 170
47. K. Bedard, and K.H. Krause The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology Physiol Rev 87 2007 245
48. J.D. Lambeth, K.H. Krause, and R.A. Clark NOX enzymes as novel targets for drug development Semin Immunopathol 30 2008 339
49. M.P. Schneider, J.C. Sullivan, and P.F. Wach Protective role of extracellular superoxide dismutase in renal ischemia/reperfusion injury Kidney Int 78 2010 374
50. Y. Fan, Y. Wang, and Z. Tang Suppression of pro-inflammatory adhesion molecules by PPAR-delta in human vascular endothelial cells Arterioscler Thromb Vasc Biol 28 2008 315
51. T. Yamanobe, F. Okada, and Y. Iuchi Deterioration of ischemia/ reperfusion-induced acute renal failure in SOD1-deficient mice Free Radic Res 41 2007 200
52. J. Kim, K.J. Jung, and K.M. Park Reactive oxygen species differently regulate renal tubular epithelial and interstitial cell proliferation after ischemia and reperfusion injury Am J Physiol Renal Physiol 298 2010 F1118